Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Meda

Showing results (191-200 of 200) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 200 results.
Msystems|November 23, 2022
Untargeted Fecal Metabolomic Analyses across an Industrialization Gradient Reveal Shared Metabolites and Impact of Industrialization on Fecal Microbiome-Metabolome InteractionsJacob J Haffner, Mitchelle Katemauswa, Thérèse S Kagone, et al.
BMC Medicine|April 25, 2017
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trialDésiré Lucien Dahourou, Madeleine Amorissani-Folquet, Karen Malateste, et al.
Plos Medicine|October 29, 2021
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in AfricaHoureratou Barry, Gaudensia Mutua, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2019
Lopinavir-Ritonavir Impairs Adrenal Function in InfantsDulanjalee Kariyawasam, Marianne Peries, Frantz Foissac, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Evaluation of Adherence of Health-Care Workers to Integrated Management of Childhood Illness Guidelines in the Context of the Free Care Program in Burkina FasoHervé B N Kpoda, Satouro Arsène Some, Manituo Aymar Serge Somda, et al.
Lancet (London, England)|July 15, 2011
Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trialThorkild Tylleskär, Debra Jackson, Nicolas Meda, et al.
BMC Infectious Diseases|June 8, 2021
The African Network for Improved Diagnostics, Epidemiology and Management of common infectious AgentsGrit Schubert, Vincent Achi, Steve Ahuka, et al.
Peerj|April 28, 2020
CoproID predicts the source of coprolites and paleofeces using microbiome composition and host DNA contentMaxime Borry, Bryan Cordova, Angela Perri, et al.
Lancet (London, England)|November 26, 2015
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trialNicolas Nagot, Chipepo Kankasa, James K Tumwine, et al.
Lancet (London, England)|May 19, 2026
Johns Hopkins Center for Humanitarian Health-Lancet Commission on health, conflict, and forced displacement: health in a world of crises and impunityPaul Spiegel, Esperanza Martinez, Orit Abrahim, et al.
Pageof 20

Showing results (191-200 of 200) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 200 results.
Msystems|November 23, 2022
Untargeted Fecal Metabolomic Analyses across an Industrialization Gradient Reveal Shared Metabolites and Impact of Industrialization on Fecal Microbiome-Metabolome InteractionsJacob J Haffner, Mitchelle Katemauswa, Thérèse S Kagone, et al.
BMC Medicine|April 25, 2017
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trialDésiré Lucien Dahourou, Madeleine Amorissani-Folquet, Karen Malateste, et al.
Plos Medicine|October 29, 2021
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in AfricaHoureratou Barry, Gaudensia Mutua, Hannah Kibuuka, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 22, 2019
Lopinavir-Ritonavir Impairs Adrenal Function in InfantsDulanjalee Kariyawasam, Marianne Peries, Frantz Foissac, et al.
The American Journal of Tropical Medicine and Hygiene|July 27, 2022
Evaluation of Adherence of Health-Care Workers to Integrated Management of Childhood Illness Guidelines in the Context of the Free Care Program in Burkina FasoHervé B N Kpoda, Satouro Arsène Some, Manituo Aymar Serge Somda, et al.
Lancet (London, England)|July 15, 2011
Exclusive breastfeeding promotion by peer counsellors in sub-Saharan Africa (PROMISE-EBF): a cluster-randomised trialThorkild Tylleskär, Debra Jackson, Nicolas Meda, et al.
BMC Infectious Diseases|June 8, 2021
The African Network for Improved Diagnostics, Epidemiology and Management of common infectious AgentsGrit Schubert, Vincent Achi, Steve Ahuka, et al.
Peerj|April 28, 2020
CoproID predicts the source of coprolites and paleofeces using microbiome composition and host DNA contentMaxime Borry, Bryan Cordova, Angela Perri, et al.
Lancet (London, England)|November 26, 2015
Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trialNicolas Nagot, Chipepo Kankasa, James K Tumwine, et al.
Lancet (London, England)|May 19, 2026
Johns Hopkins Center for Humanitarian Health-Lancet Commission on health, conflict, and forced displacement: health in a world of crises and impunityPaul Spiegel, Esperanza Martinez, Orit Abrahim, et al.
Pageof 20